Prominin-1 (CD133): New Insights on Stem & Cancer Stem Cell Biology
Since its first description fifteen years ago as a novel antigen of neural and hematopoietic stem cells, prominin-1 (alias CD133) has emerged concomitantly with stem and cancer stem cell research as an essential cell surface marker allowing identification and isolation of cells with stem cell proper...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Series: | Advances in Experimental Medicine and Biology,
777 |
| Subjects: | |
| Online Access: | https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4614-5894-4 |
Table of Contents:
- Preface
- Prominin-1 (CD133): Molecular and Cellular Features Across Species
- Prominin-2 and Other Relatives of CD133
- Prominin-1<U+0013>containing Membrane Vesicles: Origins, Formation and Utility
- Prominent Role of Prominin in the Retina
- Gene Regulation of Prominin-1 (CD133) in Normal and Cancerous Tissues
- Prominin-1 (CD133) and the Cell Biology of Neural Progenitors and Their Progeny
- CD133<U+0013>Positive Hematopoietic Stem Cells: From Biology to Medicine
- New Insights into the Renal Progenitor Cells and Kidney Diseases by Studying CD133
- CD133 Expression Strongly Correlates with the Phenotype of Very Small Embryonic/Epiblast-like Stem Cells
- New Insights into the CD133 (Prominin-1) Expression in Mouse and Human Colon Cancer Cells
- Prominin-1 (CD133) Expression in the Prostate and Prostate Cancer: A Marker for Quiescent Stem Cells
- Prominin-1 (CD133) Reveals New Faces of Pancreatic Progenitor Cells and Cancer Stem Cells: Current Knowledge and Therapeutic Perspectives
- Prominin-1 (CD133) and Metastatic Melanoma: Current Knowledge and Therapeutic Perspectives
- CD133-Positive Cells for Cardiac Stem Cell Therapy: Current Status and Outlook
- CD133+ Cells for the Treatment of Degenerative Diseases: Update and Perspectives
- Index.